A second strategy employs ASLV glycoprotein immunoadhesins, the SU glycoprotein domain fused to a rabbit IgG (Figure 5), to bind specifically to the concomitant receptor on the cell surface, to effectively reduce and/or eliminate its availability to bind incoming virus envelope glycoproteins and block infection. The gene discussed is ERVW-1; the disease is infection.